Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$887M |
| 2 |
Amazon
AMZN
|
+$857M |
| 3 |
Apple
AAPL
|
+$844M |
| 4 |
Microsoft
MSFT
|
+$802M |
| 5 |
Tesla
TSLA
|
+$606M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$760M |
| 2 |
MXIM
Maxim Integrated Products
MXIM
|
+$515M |
| 3 |
WORK
Slack Technologies, Inc.
WORK
|
+$258M |
| 4 |
Oracle
ORCL
|
+$126M |
| 5 |
PFPT
Proofpoint, Inc.
PFPT
|
+$124M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.53% |
| 2 | Financials | 13.97% |
| 3 | Healthcare | 13.42% |
| 4 | Consumer Discretionary | 11.85% |
| 5 | Communication Services | 10.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1676
Protolabs
PRLB
$2.2B
| $30.8M | ﹤0.01% |
462,755
-8,720
| -2% | -$681K |
|
|
MFA
1677
MFA Financial
MFA
$938M
| $30.8M | ﹤0.01% |
1,683,198
-161,833
| -9% | -$3.01M |
|
|
HTO
1678
H2O America
HTO
$2.65B
| $30.7M | ﹤0.01% |
465,179
+2,032
| +0.4% | +$137K |
|
|
GWB
1679
DELISTED
Great Western Bancorp, Inc.
GWB
| $30.7M | ﹤0.01% |
937,941
+4,771
| +0.5% | +$147K |
|
1680
Granite Construction
GVA
$5.49B
| $30.7M | ﹤0.01% |
775,286
+13,548
| +2% | +$536K |
|
|
CSGS
1681
DELISTED
CSG Systems International
CSGS
| $30.7M | ﹤0.01% |
636,059
+48,168
| +8% | +$2.25M |
|
1682
OSI Systems
OSIS
$3.77B
| $30.6M | ﹤0.01% |
322,582
+29,942
| +10% | +$2.92M |
|
1683
Patterson-UTI
PTEN
$4.17B
| $30.6M | ﹤0.01% |
3,397,288
+16,663
| +0.5% | +$135K |
|
|
ETWO
1684
DELISTED
E2open Parent Holdings
ETWO
| $30.5M | ﹤0.01% |
2,697,881
+1,327,560
| +97% | +$14.9M |
|
1685
McGrath RentCorp
MGRC
$2.93B
| $30.4M | ﹤0.01% |
423,194
+843
| +0.2% | +$62K |
|
1686
Greif
GEF
$5.05B
| $30.4M | ﹤0.01% |
471,208
+5,375
| +1% | +$333K |
|
1687
Pathward Financial
CASH
$1.79B
| $30.4M | ﹤0.01% |
579,935
+3,202
| +0.6% | +$159K |
|
1688
Futu Holdings
FUTU
$14.7B
| $30.3M | ﹤0.01% |
339,114
+29,879
| +10% | +$3.3M |
|
1689
StepStone Group
STEP
$4.11B
| $30.3M | ﹤0.01% |
710,149
+160,177
| +29% | +$7.08M |
|
1690
Nelnet
NNI
$4.5B
| $30.3M | ﹤0.01% |
381,978
-4,651
| -1% | -$360K |
|
1691
Quince Therapeutics
QNCX
$33.9M
| $30.2M | ﹤0.01% |
1,649
+140
| +9% | +$2.23M |
|
|
KL
1692
DELISTED
Kirkland Lake Gold Ltd Ordinary
KL
| $30M | ﹤0.01% |
719,800
+75,632
| +12% | +$3.07M |
|
|
LAZR
1693
DELISTED
Luminar Technologies
LAZR
| $30M | ﹤0.01% |
128,237
+4,701
| +4% | +$1.24M |
|
1694
Park National Corp
PRK
$3.74B
| $29.9M | ﹤0.01% |
245,576
-107
| -0% | -$12.5K |
|
1695
Lemonade
LMND
$4.03B
| $29.9M | ﹤0.01% |
446,778
+168,572
| +61% | +$13.6M |
|
|
FIRY
1696
Firy Inc
FIRY
$157M
| $29.8M | ﹤0.01% |
151,979
+3,459
| +2% | +$895K |
|
|
DNB
1697
DELISTED
Dun & Bradstreet
DNB
| $29.8M | ﹤0.01% |
1,773,062
+50,906
| +3% | +$969K |
|
1698
Horace Mann Educators
HMN
$2.08B
| $29.8M | ﹤0.01% |
748,536
+13,418
| +2% | +$532K |
|
1699
C4 Therapeutics
CCCC
$501M
| $29.8M | ﹤0.01% |
666,323
+215,781
| +48% | +$9.24M |
|
1700
StoneCo
STNE
$2.47B
| $29.8M | ﹤0.01% |
857,334
+6,424
| +0.8% | +$333K |
|
Similar funds
Geode Capital Management's Q3 2021 Portfolio in Review
As of Q3 2021, Geode Capital Management held 4,944 positions worth $743B, up 2.3% from $726B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Geode Capital Management's Q3 2021 filing shows 223 new, 2,961 increased, 1,210 reduced and 86 closed positions. Its largest new stake was Lucid Motors: 565,353 shares worth $143M. The largest sale was Alexion Pharmaceuticals, an estimated $760M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q3 2021 buy was Lucid Motors: 565,353 shares worth $143M.
- Geode Capital Management added most to Moderna in Q3 2021, an estimated $887M increase.
- Geode Capital Management's biggest Q3 2021 reduction was Oracle, cutting an estimated $126M.
- Geode Capital Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $760M.
- Geode Capital Management's ten largest holdings make up 23% of its $743B portfolio in Q3 2021.
- Geode Capital Management opened 223 new positions and closed 86 in Q3 2021.
- Geode Capital Management's portfolio value rose 2.3% quarter-over-quarter to $743B.
Based on Geode Capital Management's 13F filing for Q3 2021, filed 12 Nov 2021.